Express News | Kymera Therapeutics Inc : Btig Initiates Coverage With Buy Rating; Target Price $60

BreakingsDec 10 21:45

Kymera Therapeutics Initiated at Market Perform by BMO Capital

Dow JonesDec 6 19:17 · Ratings

BMO Capital Initiates Kymera Therapeutics(KYMR.US) With Hold Rating, Announces Target Price $55

Futu NewsDec 6 05:31 · Ratings

Cautious Optimism for Kymera Therapeutics: Hold Rating Amid Uncertainties in Innovative Protein Degradation Programs

TipRanksDec 6 05:26 · Ratings

Kymera International Acquires Coating Center Castrop GmbH

PR NewswireDec 2 22:00

Kymera Therapeutics Raised to Overweight From Equal-Weight by Wells Fargo

Dow JonesDec 2 19:39 · Ratings